ArticleFrontiers in medicine2022

PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma.

Chunyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.